Youngevity International EBIT

As of the most recent data (September 2020), YGYI shows a EBIT of $-34M. That compares with $-28M in the prior-year period — down 21.4% year over year. That is below the Consumer Discretionary sector average of $150B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YGYI's EBIT is now $-34M (was $-28M) — a 21.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Youngevity International is outperforming or lagging.

The Consumer Discretionary sector average EBIT is about $150B. Youngevity International is at $-34M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how YGYI stacks up against individual peers as well.

Tracking YGYI's ebit over time shows whether Youngevity International is scaling, shrinking, or reshaping that part of the business. The current reading is $-34M That compares with $-28M in the prior-year period — down 21.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Youngevity International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-34M) with ownership activity and broader fundamentals.